2003 JUL 21 - (NewsRx.com & NewsRx.net) -- Microbix Biosystems, Inc., (TSX) announced filing of a patent for a new proprietary vaccine technology platform that it says has the potential to offer significant economic advantages to vaccine producers.
The company filed for the patent, with the intent of establishing exclusive rights on a global basis, after successfully concluding feasibility studies. Microbix's new technology is the result of nearly 3 years of development work, reported William J. Gastle, president and CEO, "and is the second …
No comments:
Post a Comment